Harmony Biosciences Holdings vs Intellia Therapeutics

Harmony Biosciences Holdings vs Intellia Therapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Harmony Biosciences Holdings is on 57/100 and Intellia Therapeutics on 40/100.

Harmony Biosciences Holdings logo
Harmony Biosciences HoldingsBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
Try Harmony Biosciences Holdings
Intellia Therapeutics logo
Intellia TherapeuticsA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Try Intellia Therapeutics

Where each one leads

Harmony Biosciences Holdings

  • our overall score: 57/100 against 40/100
  • funding raised: $401M against $310M

Intellia Therapeutics

  • LinkedIn following: 71,640 against 22,304

At a glance

MeasureHarmony Biosciences HoldingsIntellia Therapeutics
What it isBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
CategoryBiotech, MedTech, HealthTech, Drug DiscoveryBiotech, MedTech, Genomics, Drug Discovery
Sells toBusiness modelB2BB2B
OfferingServicesPlatform
Founded20172014
HeadquartersPlymouth Meeting, United StatesCambridge, United States
StatusActiveActive

Size, funding and growth

MeasureHarmony Biosciences HoldingsIntellia Therapeutics
Employees332Not published
Total funding$401M$310M
Latest roundIPOSeries C
LinkedIn followers22,30471,640

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureHarmony Biosciences HoldingsIntellia Therapeutics
StartupHub scoreOur 0-100 rating57/10040/100
Traction60/10040/100
Team30/10070/100
Search visibility33/10031/100
Quality68/10035/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)D (42/100)
Domain ratingLink authority, 0-10055/10060/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureHarmony Biosciences HoldingsIntellia Therapeutics
CDNCloudflareCloudflare
CMSWordPressWordPress
FrameworksNot detectedJquery
AnalyticsGoogle Tag ManagerGoogle Analytics 4, Hotjar, Fathom

Harmony Biosciences Holdings vs Intellia Therapeutics: common questions

Which is better, Harmony Biosciences Holdings or Intellia Therapeutics?

On our 0-100 score Harmony Biosciences Holdings rates higher (57/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.

How do Harmony Biosciences Holdings and Intellia Therapeutics compare on the numbers?

Harmony Biosciences Holdings leads on our overall score (57/100 against 40/100), funding raised ($401M against $310M). Intellia Therapeutics leads on LinkedIn following (71,640 against 22,304).

Read the full Harmony Biosciences Holdings review and pricing or the Intellia Therapeutics review and pricing. You can also browse other Harmony Biosciences Holdings alternatives we track.